6325-13-9

6325-13-9 structure

Name: N-[(E)-(6-oxo-1-cyclohexa-2,4-dienylidene)methyl]-4-[3-[[[(E)-(6-oxo-1-cyclohexa-2,4-dienylidene)methyl]amino]carbamoyl]propylsulfanyl]butanehydrazide
Chemical Name: N'-[(E)-(6-oxocyclohexa-2,4-dien-1-ylidene)methyl]-4-[4-oxo-4-[2-[(E)-(6-oxocyclohexa-2,4-dien-1-ylidene)methyl]hydrazinyl]butyl]sulfanylbutanehydrazide
CAS Number: 6325-13-9
Molecular Formula: C₂₂H₂₆N₄O₄S
Molecular Weight: 442.53
Catalog: Signaling Pathways NF-κB Keap1-Nrf2
Create Date: 2017-09-01 18:45:00
Modify Date: 2024-04-05 01:21:11
Nrf2-IN-3 (Compound R16) is a Nrf2 inhibitor. Nrf2-IN-3 binds KEAP1 mutants (G333C mKEAP1) and repairs the disrupted KEAP1/NRF2 interactions. Nrf2-IN-3 sensitizes KEAP1-mutated cancer cells to Cisplatin (HY-17394) and Gefitinib (HY-50895) by repairing the mKEAP1/NRF2 complex[1].

Name	N'-[(E)-(6-oxocyclohexa-2,4-dien-1-ylidene)methyl]-4-[4-oxo-4-[2-[(E)-(6-oxocyclohexa-2,4-dien-1-ylidene)methyl]hydrazinyl]butyl]sulfanylbutanehydrazide
Synonyms	4,4'-Sulfandiyl-di-buttersaeure-bis-salicylidenhydrazid 4,4'-sulfanediyl-di-butyric acid bis-salicylidenehydrazide

Description	Nrf2-IN-3 (Compound R16) is a Nrf2 inhibitor. Nrf2-IN-3 binds KEAP1 mutants (G333C mKEAP1) and repairs the disrupted KEAP1/NRF2 interactions. Nrf2-IN-3 sensitizes KEAP1-mutated cancer cells to Cisplatin (HY-17394) and Gefitinib (HY-50895) by repairing the mKEAP1/NRF2 complex[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> NF-κB >> Keap1-Nrf2
References	[1]. Aboulkassim T, et al. A NRF2 inhibitor selectively sensitizes KEAP1 mutant tumor cells to cisplatin and gefitinib by restoring NRF2-inhibitory function of KEAP1 mutants. Cell Rep. 2023 Sep 12;42(9):113104.